|
Depression: Begin Healing with Alpha-Stim® |
|
For over 27 years, Alpha-Stim® has been giving hope to people that suffer with Chronic Pain, Anxiety, Insomnia and Depression. If you, or someone you know, are seeking an effective alternative to prescription medication, then search no further. You've come to the right place. It's time to Begin Healing.
Treating Anxiety, Depression, and/or Insomnia with CES
The Alpha-Stim® 100 treats anxiety, depression, and/or insomnia with microcurrent using a method called cranial electrotherapy stimulation (CES). The treatment is very simple. The current is applied by easy to use clip electrodes that attach on the ear lobes. Used just 20 to 40 minutes every day, every other day, or on an as-needed basis, it can help induce a pleasant, relaxed feeling of well being. The Alpha-Stim® 100 is well tolerated and very safe in contrast to drugs used in the treatment of mood disorders, many of which have been proven to have undesirable side effects and can be addictive. Unlike drugs, the Alpha-Stim® 100 leaves the mind alert. Anxiety reduction is usually experienced during treatment. Depression and insomnia control is generally experienced after one to two weeks of daily treatment. CES can also help treat the underlying mood disorders associated with pain.
It may be used as an adjunct to medication and/or psychotherapy. After treatment, there are usually no physical limitations imposed so the majority of people can resume normal activities immediately. Maintenance of a relaxed, yet alert state is generally achieved with treatments three times per week. As a result, the Alpha-Stim® 100 is suitable for clinical or home use.
Alpha-Stim® is Proven More Efficacious.
Alpha-Stim® has shown in peer reviewed studies, that it is more efficacious beyond a placebo effect than some of the leading depression treatment medication on the market. It provides significant relief to 9 out of 10 patients that try it.1
Depression Treatment Comparison
Alpha-Stim® Reviewed
"Given that Alpha-Stim raises serotonin and norepinephrine levels, and has a neutralizing effect on somatic pain generators, I predict this therapy will become a mainstream modality for reducing medication reliance and enhancing function in patients with FMS."
-Stephen E. Plotnick, M.D. Virginia Beach, VA, Advance for Directors in Rehabilitation Full Article



